Real-World Evaluation of GLP-1 Receptor Agonist Therapy Persistence, Adherence and Therapeutic Inertia Among Obese Adults with Type 2 Diabetes

INTRODUCTION: In type 2 diabetes (T2D), key barriers to optimal glycaemic control include lack of persistence with treatment, reduced medication adherence and therapeutic inertia. This study aimed to assess the impact of these barriers in obese adults with type 2 diabetes treated with a GLP-1 recept...

Descripción completa

Detalles Bibliográficos
Autores principales: Palanca, Ana, Ampudia-Blasco, F. Javier, Calderón, José Miguel, Sauri, Inmaculada, Martinez-Hervás, Sergio, Trillo, José Luis, Redón, Josep, Real, José T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064368/
https://www.ncbi.nlm.nih.gov/pubmed/36847952
http://dx.doi.org/10.1007/s13300-023-01382-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064368/
https://www.ncbi.nlm.nih.gov/pubmed/36847952
http://dx.doi.org/10.1007/s13300-023-01382-9

Ejemplares similares